Skip to main content
Clinical Trials/NCT02630576
NCT02630576
Completed
Not Applicable

Neurostimulation and Electromyographs Assessment of th TetraGraph in Healthy Volunteers

University of Debrecen1 site in 1 country20 target enrollmentJune 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Electromyography
Sponsor
University of Debrecen
Enrollment
20
Locations
1
Primary Endpoint
Primary performance assessment of TetraGraph device
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

TetraGraph is a newly developed EMG-based (electromyograph), quantitative, battery-powered neuromuscular monitoring system intended for daily clinical use. The primary aim of this clinical investigation is to examine the applicability (ease of use, equipment need, etc.), repeatability (precision or internal consistency) and performance (signal quality, accuracy of outcome, voltage of stimulation output before and during a stimulus) and tolerability of the Tetragraph device in healthy volunteers.

Detailed Description

The primary endpoint will be assessment of the ability of the TetraGraph prototype to deliver neuro-stimulation, and assessment of the ability to acquire muscle action potentials and record these evoked responses on the SD-card. The study will be performed on healthy volunteers - 10 male and 10 female. Testing will be done at two separate stimulation/recording sites: ulnar nerve stimulation/abductor digiti minimi (ADM) muscle recording; and ulnar nerve stimulation/adductor pollices (AP) muscle recording. The side of testing (RIGHT vs. LEFT hand) will be determined a priori and randomly by the principal investigator, such that 10 volunteers each will be tested on the RIGHT and 10 on the LEFT hands. At each stimulating/recording site two stimulation protocols (single twitch stimulation and train-of-four stimulation) will be performed with growing current intensity (10-60 mA (milliAmps), in a 10 mA step-up fashion). Volunteers will rate the tolerability of each stimulation protocols on a visual analogue scale. EMG data will be recorded on the SD card and evaluated off-line.

Registry
clinicaltrials.gov
Start Date
June 2015
End Date
December 2016
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Tamas Vegh, MD

MD, PhD

University of Debrecen

Eligibility Criteria

Inclusion Criteria

  • Age 18 years or older
  • Volunteer is American Society of Anesthesiology (ASA) physical status I-III (Tabl
  • Volunteer has provided written informed consent

Exclusion Criteria

  • Presence of an underlying neuromuscular disease
  • Use of medications known to interfere with neuromuscular transmission
  • Presence of renal or hepatic disease
  • Subject has only one upper extremity
  • Subject has open sores at the skin sites needed for electrode application

Outcomes

Primary Outcomes

Primary performance assessment of TetraGraph device

Time Frame: Subjects will be followed for the time of measurements an expected avarage of one hour

The primary objective of this study is the assessment of the ability of the prototype to deliver neuro-stimulation, and assessment of the ability to acquire muscle action potentials and record these evoked responses on the SD-card.

Secondary Outcomes

  • Secondary performance assessment of TetraGraph Device(Subjects will be followed for the time of measurements an expected avarage of one hour)

Study Sites (1)

Loading locations...

Similar Trials